80 results about "Sphincter muscle" patented technology

A rod-like or tube-like sphincteric closure device is micro-invasively implanted beneath the surface of the posterior mucosal wall to elevate the mucosa and close the lumen, by using a delivery device operated through the urethra. To initiate voiding, the muscle-rich anterior urethral wall contracts and widens the lumen beyond the closing or elevating range of the sphincteric closure device. For urethral obstruction, repelling magnets are micro-invasively implanted beneath the surface of mucosa with the delivery device through the urethra, to widen the lumen with magnetic force.

A variety of passive intragastric implant devices for obesity treatment are disclosed. Such passive devices do not autonomously change shape, but instead react within the stomach to induce satiety. The devices may take up volume within the stomach, thus reducing the intake capacity. Additionally, the devices may contact areas within the stomach, such as the cardia surrounding the esophageal sphincter, or the greater and lesser curvatures in the middle of the stomach, to stimulate satiety-inducing nerves. Some devices may combine two or more of these satiety-inducing features. Methods of implant are disclosed including compressing the devices within a delivery tube and transorally advancing the devices through the esophagus to be deployed within the stomach. Removal of the devices occurs in the reverse.

A method and apparatus for minimizing fecal incontinence in a subject, is disclosed. An inhibition action incontinence device includes a truncated cone with an angled concavity at a top portion. The truncated cone is positioned at the external opening of the anal canal. The truncated cone may be positioned to effect a positive pressure on the external sphincter muscles and the anal slit across the peri-anal tissues. It is believed that the truncated cone exploits the voluntary inhibition action of the external sphincter muscles and the simple mechanical closure of the anal slit to decrease fecal incontinence and soiling.

The present invention relates to a cell therapy product which is intended for regenerating a sphincter muscle and which contains stem cells derived from amniotic fluid, and more particularly, to a cell therapy product which is intended for regenerating the sphincter vesicae and which contains stem cells derived from amniotic fluid. Also, the cell therapy product of the present invention can be provided in the form of a formulation for administration through injection, said formulation being injected into a hydrogel complex to thereby improve the effects thereof. The composition including stem cells derived from amniotic fluid according to the present invention enables stem cells to be differentiated into muscles in the body of individual suffering from urinary incontinence by directly injecting the composition into the individual, thus effectively controlling urinary incontinence by recovering muscle functions. That is, the stem cells derived from amniotic fluid of the present invention are differentiated into muscles in-situ, and the differentiation into muscles can thus be achieved only with cells in order to recover muscle functions.

The invention relates to a medicament for treating uracratia and a preparation method thereof. The medicament is prepared from raw radix astragalis, bighead atractylodes rhizome, parasitic loranthus, teasel, cornus, calcined fossil fragments, calcined oyster, sevenlobed yam rhizome and prepared liquorice root through compatibility, can raise yang, tonify liver and kidney and strengthen bones and muscles, invigorate spleen and supplement qi, benefit qi and nourish yin, strengthen lumbus and knees and reinforce body immunity, can remove dampness and reinforce dryness, eliminate dampness and induce diuresis, eliminate wind-damp, dredge collaterals, promote blood circulation for diminishing swelling, prevent miscarriage and nourish blood, stop bleeding and astringe intestine, relieve soreness and pain, soften hardness to dissipate stagnation, accelerate blood circulation, dispel wind evil and remove dampness, moisten the lungs and detoxify, diminish inflammation and relieve pain, reduce or retard influence of other diseases on uracratia and induce diuresis and promote micturition, can relieve convulsion and calm the nerves, constrain yin for hidroschesis, strengthen exterior and reducing sweat, arrest sweating for securing essence, astringe for induce astringency, regulate and restrain constriction and extension of sphincter vesicae and treat frequent micturition. The medicament disclosed by the invention can reinforce immunity of a patient, reduce or retard influence of other diseases on uracratia, accelerate blood circulation and micturition, strengthen control of the sphincter vesicae and has an obvious curative effect of treating uracratia.

The invention discloses a compound lidocaine aerosol and a preparation method thereof. The compound lidocaine aerosol comprises the following components in parts by weight: 0.2-3.5 parts of lidocaine,0.2-3.5 parts of propylamine caine, 1-3.5 parts of 0.1 M sodium hydroxide, 2-35 parts of propellant, 1-17.6 parts of polyvinyl alcohol and 0.1-1.75 parts of rutin derivative. Under the condition of not containing penetrant and surfactant components, lidocaine and propylamine caine in a basic group form are released to the subcutaneous layer, and polyvinyl alcohol is used for forming a film on thesurface of the skin, so that the dosage of lidocaine and propylamine caine is reduced, and the safety of clinical use is enhanced; the treatment of male premature ejaculation is mainly used for inhibiting the expansion of the minor artery and capillary anterior sphincter of the cavernous body of the penis, so that the smooth muscle is relaxed, and the blood flow volume is increased; the rutin derivative is added, the elasticity and permeability of the drug are improved by improving the capillary function, and adverse reactions such as vascular bleeding caused by long-term use of traditional lidocaine drugs are avoided.

The invention belongs to the technical field of haemorrhoids treatment, and discloses a medicament for treating haemorrhoids. The medicament is prepared from, by mass, 3-5 parts of ozonized oil, 1-3 parts of rhizoma bletillae extracts, 1-3 parts of sophora fruit extracts and 1-3 parts of radix saposhnikoviae extracts. The invention further provides a preparation method of the medicament for treating the haemorrhoids. The medicament has the effects of quickly diminishing inflammation, killing bacteria, relieving pain and stop bleeding, the perianal sphincter muscle can be effectively made to contract, and recurrence of the hemorrhoids can be prevented while the hemorrhoids is treated.

The invention relates to an adjustable expansion three-cavity two-bag lacrimal passage catheterization tube for lacrimal passage blockage. The three-cavity two-bag lacrimal passage catheterization tube comprises a side tube, a lacrimal passage main support catheter, a wire passing tunnel, an expandable ball bag, an inner and outer tube tight connection position, an expendable ball post, a ball bagwater injection fine tube, a ball post gas injection fine tube, and a ball post gas injection tube fixing loop, wherein the expandable ball bag surrounds the upper section of the lacrimal passage main support catheter; the expendable ball post surrounds the lower section of the lacrimal passage main support catheter; the inner and outer tube tight connection position is arranged between the expandable ball bag and the expandable ball post. The adjustable expansion three-cavity two-bag lacrimal passage catheterization tube for lacrimal passage blockage has the advantages that the ball bag sizein the lacrimal sac part can be regulated in an individualized way according to the lacrimal sac size of a patient; the lacrimal passage catheterization tube is stabilized; the falling is prevented;meanwhile, the ball post in the lacrimonasal duct position can be regularly moved and expanded; the loose adhesion tissues can be reduced; the lacrimonasal duct position blockage condition is relieved; the functions of lacrimal passage sphincter muscle is trained; the operation is simple; convenience and fast are realized; the epiphora state of the patient can be better avoided; the life quality of the patient is improved.